Effects of selective angiotensin II type 1 receptor blockade with losartan on arterial compliance in patients with mild essential hypertension

Blood Pressure

Volumn 8, Issue 4, 1999, Pages 214-219

  Klemsdal, Tor Ole ^a   Moan, Andreas ^a   Kjeldsen, Sverre E ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angiotensin II type 1 receptor blockade; Arterial compliance

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTERY COMPLIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RECEPTOR BINDING; ESSENTIAL HYPERTENSION; HUMAN; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033367533     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370599439599     Document Type: Article

References (35)

1. Glasser SP, Arnett DK, McVeigh GE, et al. Vascular compliance and cardiovascular disease: a risk factor or a marker? Am J Hypertens 1997; 10: 1175-89.
2. Messerli FH, Frohlich ED, Ventura HO. Arterial compliance in essential hypertension. J Cardiovasc Pharmacol 1985; 7: 533-35.
3. Simon AC, Levenson J, Bouthier JD, et al. Effects of chronic administration of enalapril and propranolol on the large arteries in essential hypertension. J Cardiovasc Pharmacol 1985; 7: 856-61.
4. Safar ME. Pulse pressure in essential hypertension: clinical and therapeutical implications. J Hypertens 1989; 7: 769-76.
5. O'Rourke MF. Arterial stiffness, systolic blood pressure and logical treatment of arterial hypertension. Hypertension 1990; 15: 339-47.
6. Himmelmann A, Hedner T, Hansson L, et al. Isolated systolic hypertension: an important cardiovascular risk factor. Blood pressure 1998; 7: 197-07.
7. SHEP cooperative research group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.
8. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-64.
9. Simon AC, Levenson JA, Levy BY, et al. Effect of nitroglycerin on peripheral large arteries in hypertension. Brit J Clin Pharmacol 1982; 14: 241-46.
10. Westling H, Jansson L, Jonson B, et al. Vasoactive drugs and elastic properties of human arteries in vivo, with special reference to the action of nitroglycerine. Eur Heart J 1984; 5: 609-16.
11. Chau NP, Simon A, Vilar J, et al. Active and passive effects of antihypertensive drugs on large artery diameter and elasticity in human essential hypertension. J Cardiovasc Pharmacol 1992; 19: 78-85.
12. Barenbrock M, Spieker C, Hoeks AP, et al. Effect of lisinopril and metoprolol on arterial distensibility. Hypertension 1994; 23 Suppl I: I-161-I-163.
13. Kelly RP, Daley JE, Avalio AP, et al. Arterial dilation and reduced wave reflection: benefit of dilevalol in hypertension. Hypertension 1989; 14: 14-21.
14. Watkins RW, Sybertz EJ, Antonellis A, et al. Effects of the antihypertensive dilevalol on large artery compliance in anaesthetized dogs. J Cardiovasc Pharmacol 1987; 10 Suppl 11: S58-63.
15. Klemsdal TO, Mundal HH, Gjesdal K. Effects of carvedilol versus atenolol on arterial pulse curves (plethysmography) and finger temperatures after hand cooling. Eur J Clin Pharmacol 1996; 50: 483-9.
16. Asmar RG, Benetos A, Chaouche-Teyera K, et al. Comparison of effects of felodipine versus hydrochlorthiazide on arterial diameter and pulse-wave velocity in essential hypertension. Am J Cardiol 1993; 72: 794-8.
17. Goodfriend T, Elliot ME, Catt KJ. Angiotensin receptors and their antagonists. New Engl J Med 1996; 334: 1649-54.
18. Goa KL, Wagstaff AJ. Losartan Potassium. A review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Drugs 1996; 51: 820-45.
19. 1-receptor antagonist losartan on arterial compliance in hypertensives. J Hypertens 1994; 12 Suppl 3: S98.
20. Moan A, Høieggen A, Seljeflot I, et al. The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity. J Hypertens 1996; 14: 1093-97.
21. Lund F. Digital pulse plethysmography in studies of the hemodynamic response to nitrates - A survey of recording methods and principles of analysis. Acta Pharmacol Toxicol 1986; 59 Suppl VI: 79-96.
22. Klemsdal TO, Mundal HH, Gjesdal K. Mechanisms of tolerance during treatment with nitroglycerin patches for 24 hours. Eur J Clin Pharmacol 1996; 51: 227-30.
23. Craige E Heart sounds, in Braunwald E (ed): Heart disease: a textbook of cardiovascular medicine. W.B. Saunders Company, Philadelphia, Eastbourne, Toronto, 1980: 39-69.
24. Nishimura H, Kubo S, Ueyama M, et al. Peripheral hemodynamic effects of captopril in patients with congestive heart failure. Am Heart J 1989; 117: 100-5.
25. Vanhoutte PM, Auch-Schwelk W, Biondi ML, et al. Why are converting enzyme inhibitors vasodilators? Br J Clin Pharmacol 1989; 28: 95S-04S.
26. Benetos A, Topouchian J, Richard S, et al. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertens 1995; 26: 44-7.
27. Klemsdal TO, Andersson TL, Matz J, Ferns GA, Gjesdal K, Anggard EE. Vitamin E restores endothelium dependent vasodilation in cholesterol fed rabbits: in vivo measurements by photoplethysmography. Cardiovasc Res 1994; 28: 1397-02.
28. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in Angiotensin II-induced but not catecholamin-induced hypertension. Circulation 1997; 95: 588-93.
29. Dawber TR, Thomas HE Jr, McNamara PM. Characteristics of the dicrotic notch of the arterial pulse wave in coronary heart disease. Angiology 1973; 24: 244-55.
30. Imhof PR, Ott B, Frankhauser P, et al. Difference in nitroglycerin dose-response in the venous and arterial beds. Eur J Clin Pharmacol 1980; 18: 455-60.
31. Porchet H, Bircher J. Digital plethysmography (DPG), a non-invasive method to assess the bioavailability of glyceryl nitrate. Experientia 1981; 37: 674.
32. Klemsdal TO, Mundal HH, Rudberg N, Gjesdal K. A new isosorbide dinitrate extended release formulation: pharmacokinetic and clinical parameters in patients with stable angina pectoris. Eur J Clin Pharmacol 1994; 47: 351-4.
33. Sundberg S, Castrén M. Drug- and temperature-induced changes in peripheral circulation measured by laser-Doppler flowmetry and digital-pulse plethysmography. Scand J Clin Lab Invest 1986; 46: 359-65.
34. Stengele E, Winkler F, Trenk D, et al. Digital pulse plethysmography as a non-invasive method for drug-induced changes in left ventricular preload. Eur J Clin Pharmacol 1996; 50: 279-82.
35. Honda T, Hamada M, Matsumoto Y, et al. Noninvasive physiological assessment of vascular wall sclerosis using carotid pulse tracing and cine magnetic resonance. Angiology 1995; 46: 369-74.